Abstract:Background: Mesenchymal stem cells (MSCs) selectively differentiate into adipocytes or osteoblasts, and several molecules control the fate determination of MSCs. Understanding these key checkpoints greatly contributes to the ability to induce specific MSC differentiation for clinical applications. In this study, we aimed to explore whether TNF receptor-associated factor 4 (TRAF4) affects MSC adipogenic differentiation, which we previously reported that could positively regulated the osteogenic differentiation. Methods: Western blotting and Real-time Polymerase Chain Reaction were used to detected the expression pattern of TRAF4 during adipogenic differentiation. Lentivirus was constructed to regulate TRAF4 expression, and oil red O staining and Western blotting were used to assess its role in adipogenesis, which was confirmed in vivo by implanting an MSC-matrigel mixture into nude mice. Western blotting was used to detect the activated signaling pathways, and a specific inhibitor and agonist were used to clear the roles of the key signaling pathways. Additionaly, Co-Immunoprecipitation was conducted to find that Pyruvate kinase isozyme type M2 (PKM2) interacts with TRAF4, and to further explore their binding and functional domains. Finally, an RNA-binding protein immunoprecipitation assay and Western blotting were used to detect whether N6-methyladenosine mediates the decreased TRAF4 expression during adipogenic differentiation. Findings: The results demonstrated that TRAF4 negatively regulates MSC adipogenesis in vitro and in vivo. Mechanistically, we revealed that TRAF4 binds to PKM2 to activate the kinase activity of PKM2, which subsequently activates beta-catenin signaling and then inhibits adipogenesis. Furthermore, TRAF4 downregulation during adipogenesis is regulated by ALKBH5-mediated N6-methyladenosine RNA demethylation. Interpretation: TRAF4 negatively regulates the adipogenesis of MSCs by activating PKM2 kinase activity, which may act as a checkpoint to fine-tune the balance of adipo-osteogenic differentiation, and suggests that TRAF4 may be a novel target of MSCs in clinical use and may also illuminate the underlying mechanisms of bone metabolic diseases. (C) 2020 The Author( s). Published by Elsevier B.V.

IRS-1 targets TAZ to inhibit adipogenesis of rat bone marrow mesenchymal stem cells through PI3K-Akt and MEK-ERK pathways.

Exchange protein activated by cyclic adenosine monophosphate regulates the switch between adipogenesis and osteogenesis of human mesenchymal stem cells through increasing the activation of phosphatidylinositol 3-kinase.

Role of P38, ERK1/2, Focal Adhesion Kinase, RhoA/ROCK and Cytoskeleton in the Adipogenesis of Human Mesenchymal Stem Cells.

Insulin receptor substrate-1 inhibits high-fat diet-induced obesity by browning of white adipose tissue through miR-503

Insulin receptor substrate 1 regulates the cellular differentiation and the matrix metallopeptidase expression of preosteoblastic cells.

Activation Of Protein Kinase A And Exchange Protein Directly Activated By Camp Promotes Adipocyte Differentiation Of Human Mesenchymal Stem Cells

Critical Role of Phosphoinositide 3-Kinase Cascade in Adipogenesis of Human Mesenchymal Stem Cells

TRAF4 Acts As a Fate Checkpoint to Regulate the Adipogenic Differentiation of MSCs by Activating PKM2

[ICAM-1 regulates differentiation of MSC to adipocytes via activating MAPK pathway].

SIRT1 Inhibits Adipogenesis and Promotes Myogenic Differentiation in C3H10T1/2 Pluripotent Cells by Regulating Wnt Signaling.

ZBP1 (DAI/DLM-1) promotes osteogenic differentiation while inhibiting adipogenic differentiation in mesenchymal stem cells through a positive feedback loop of Wnt/β-catenin signaling

Inhibition of Notch Signaling Promotes the Adipogenic Differentiation of Mesenchymal Stem Cells Through Autophagy Activation and PTEN-PI3K/AKT/mTOR Pathway

Long noncoding RNA repressor of adipogenesis negatively regulates the adipogenic differentiation of mesenchymal stem cells through the hnRNP A1‐PTX3‐ERK axis

miR-196b-5p controls adipocyte differentiation and lipogenesis through regulating mTORC1 and TGF- signaling

METTL3 inhibits BMSC adipogenic differentiation by targeting the JAK1/STAT5/C/EBPβ pathway via an mA-YTHDF2-dependent manner.

Microrna-196A Promotes Osteogenic Differentiation and Inhibit Adipogenic Differentiation of Adipose Stem Cells Via Regulating Β-Catenin Pathway.

LKB1 Promotes the Transformation of Bone Marrow Mesenchymal Stem Cells into Adipocytes Under Oxidative Stress via AMPK-mTOR Signaling Pathway.

TSA Inhibits Adipogenic Differentiation in Mesenchymal Stem Cells by Activating ERK and p38 Kinase

Mitochondrial Respiration Regulates Adipogenic Differentiation of Human Mesenchymal Stem Cells.

Metastasis Suppressor 1 Interacts with Protein Tyrosine Phosphatase Receptor‐δ to Regulate Adipogenesis

Tetramethoxystilbene, a selective CYP1B1 inhibitor, suppresses adipogenesis of C3H10T1/2 pluripotent stem cells